Skip to content
DraconiticResearch
Search Sources API
186,123 studies31 sourcesUpdated 21 min ago
Peer-reviewedCC BY 4.0Accounts of Materials Research

Graphene Oxide: Designing a Functional Smarter Material for Advanced Biomedicine

Abstract

Graphene oxide (GO) has emerged as one of the most extensively studied two-dimensional (2D) materials thanks to its large surface area and abundance of functional groups, which enable applications across energy, catalysis, electronics, construction, and mobility. Its exceptional dispersibility in water further expands its use in the biomedical field. However, researchers have consistently expressed concerns about the limited control over GO's chemical composition and structural heterogeneity. These factors are often overlooked, strongly affecting reproducibility in both synthesis and applications. Because GO is considered a promising platform for advanced drug delivery, achieving reproducible preparation and precise structural control is essential to make it a reliable alternative to the many nanomaterials currently explored for nanomedicine.Motivated by these challenges, our work has focused on identifying and controlling the key parameters that govern GO structure and surface chemistry. Over the past decade, we have developed methods to produce GO with controlled and tunable chemical structures, clarified the reactivity of its major functional groups, and developed robust strategies for post-functionalizing GO with therapeutic agents, targeting ligands, and imaging dyes. In parallel, we have established systematic approaches to evaluate GO's biocompatibility and biodegradability, revealing how specific physicochemical features influence biological responses and clearance pathways.

Together, these findings provide a unified framework linking GO's synthesis, chemical modification, and biological behavior. By integrating chemical control, functional performance, and safety assessment, our work outlines a coherent strategy for the rational design of GO-based biomedical materials. We believe this Account offers a solid foundation for the targeted exploitation of GO in nanomedicine and will help facilitate its eventual clinical translation.

Related

  1. Designing advanced luminescent materials via imidazole incorporation: Integrated experimental and DFT/TD-DFT analysis
    Hanen Jomaa, Boubaker Zaidi, Walid Taouali +7
    Scientific AfricanPeer-reviewedCC BY 4.0Full textMaterials & polymersHAL
  2. Production and thermal performance evaluation of graphene nanoplatelets/Al₂O₃-reinforced Al6061–Cu hybrid thermal interface material
    Surrya Prakash DilliBabu, Naveen Kilari, Grandhamala Sravanthi +7
    Scientific ReportsPeer-reviewedCC BY-NC-ND 4.0Materials & polymersCrossref
  3. Valorization of coconut waste and Lawsonia inermis for the synthesis of NH4CoPO4·H2O/graphene oxide nanocomposite sensor material for ultrasensitive dopamine detection
    V. Kavitha, G. Lakshmi Priya
    RSC advancesPeer-reviewedCC BY-NCFull textGeneral chemistryEurope PMCPMC
  4. Design and fabrication of graphene oxide-based nanocomposites with tuneable morphological properties for advanced supercapacitor applications
    Mohammad Mizanur Rahman Khan, Md Mahamudul Hasan Rumon, Jae-Ho Jeong
    RSC advancesPeer-reviewedCC BYFull textMaterials & polymersEurope PMCPMC
  5. Advanced N-Graphene-Based Electromagnetic Shields via Microwave Plasma Induced Synthesis
    Elena Tatarova, Neli Bundaleska, Edgar Felizardo +12
    NanomaterialsPeer-reviewedCC BY 4.0Materials & polymersCrossref
BibTeX
@article{menardmoyon2026graphene,
  title = {{Graphene Oxide: Designing a Functional Smarter Material for Advanced Biomedicine}},
  author = {Cécilia Ménard-Moyon and Yuta Nishina and Alberto Bianco},
  journal = {Accounts of Materials Research},
  year = {2026},
  month = oct,
  doi = {10.1021/accountsmr.5c00362},
  url = {https://hal.science/hal-05770616v1},
  note = {CC BY 4.0},
}
RIS
TY  - JOUR
TI  - Graphene Oxide: Designing a Functional Smarter Material for Advanced Biomedicine
AU  - Cécilia Ménard-Moyon
AU  - Yuta Nishina
AU  - Alberto Bianco
PY  - 2026
DA  - 2026/10/03
JO  - Accounts of Materials Research
DO  - 10.1021/accountsmr.5c00362
UR  - https://hal.science/hal-05770616v1
AB  - Graphene oxide (GO) has emerged as one of the most extensively studied two-dimensional (2D) materials thanks to its large surface area and abundance of functional groups, which enable applications across energy, catalysis, electronics, construction, and mobility. Its exceptional dispersibility in water further expands its use in the biomedical field. However, researchers have consistently expressed concerns about the limited control over GO's chemical composition and structural heterogeneity. These factors are often overlooked, strongly affecting reproducibility in both synthesis and applications. Because GO is considered a promising platform for advanced drug delivery, achieving reproducible preparation and precise structural control is essential to make it a reliable alternative to the many nanomaterials currently explored for nanomedicine.Motivated by these challenges, our work has focused on identifying and controlling the key parameters that govern GO structure and surface chemistry. Over the past decade, we have developed methods to produce GO with controlled and tunable chemical structures, clarified the reactivity of its major functional groups, and developed robust strategies for post-functionalizing GO with therapeutic agents, targeting ligands, and imaging dyes. In parallel, we have established systematic approaches to evaluate GO's biocompatibility and biodegradability, revealing how specific physicochemical features influence biological responses and clearance pathways.  Together, these findings provide a unified framework linking GO's synthesis, chemical modification, and biological behavior. By integrating chemical control, functional performance, and safety assessment, our work outlines a coherent strategy for the rational design of GO-based biomedical materials. We believe this Account offers a solid foundation for the targeted exploitation of GO in nanomedicine and will help facilitate its eventual clinical translation.
SN  - 2643-6728
ER  -